human-grade tirzepatide Retatrutide vs. Tirzepatide: What's The Difference? – Forbes Health Compounded Tirzepatide Online for Diabetes

Dosing in the Phase 3 Diabetes Trial (TRANSCEND-T2D-1) A1C reduction: -1.7% to -2.0% across doses (from baseline 7-9.5%) Weight loss at 12 mg: 16.8% (-36.6 lbs) at 40 weeks Discontinuation due to adverse events was relatively low across all doses, similar to the patterns seen in TRIUMPH-4 The diabetes population typically loses less weight on GLP-1 drugs than the obesity-only population, which is consistent with what was observed: ~17% weight loss in T2D vs

You want to improve your overall metabolic health, not just the number on the scale

By comparison, testosterone-replacement therapies (TRTs) introduce significantly more risk than supplements

Higher GI meals make you less satiated for a shorter time